Global Key Opinion Leaders

Dr. Isaac R. Rodriguez-Chavez is a biomedical and regulatory leader with expertise in Infectious Diseases, Viral Immunology, Viral Oncology (Infectious Diseases), and Vaccinology. Currently, he is an independent consultant for Scientific, Clinical and Regulatory affairs. Past positions in the last 30+ years include: Senior Vice President for Scientific, Clinical Affairs, leading the Strategy of the Global Center of Excellence for Decentralized Clinical Trials at PRA Health Sciences and ICON plc; FDA, CDER Senior Officer for Clinical Research Methodology, Regulatory Compliance and Policy Development modernizing clinical research through Real World Evidence and Decentralized Clinical Trials enabled by Digital Health Technologies and electronic Clinical Outcome Assessments (eCOAs); CEO and Founder, 4Biosolutions Biomedical Consulting Firm; Vice President, Research, Texas Biomedical Research Institute; Director of HIV Clinical Research Programs at National Institute of Allergy and Infectious Diseases (NIAID) and National Institute of Dental and Craniofacial Research (NIDCR), National Institutes of Health (NIH); Senior Clinical Scientist, Schering Plough Corp. – Merck & Corp.; Scientist, Columbia University; Scientist, Polar Biotechnology Company and Venezuelan Institute for Scientific Research (IVIC). He has a PhD in Virology and Immunology; a MS in Microbiology; a MHS in Clinical Research and Health Sciences; and a B.S. in Biology. He also has 5 years of postdoctoral specialty experience in Clinical Research (phases 1 & 2 trials) linked to in AIDS Malignancies, Immuno-Oncology and Viral Immunology (Infectious Diseases) done at the U.S. NIA and NCI, NIH.

Dr. Rodriguez-Chavez is a Founding Board Member of the Digital Medical Society (DiME). He is also a co-chair of the DiME’s Research Committee, driving digital medicine globally. He is a regulatory Advisor and Vice-Chair of the Institute of Electrical and Electronics Engineers (IEEE) fostering industry standards on DCTs and DHTs. He is a former Leadership Council Board Member of the Decentralized Trials & Research Alliance (DTRA). He is a Board Member of the Hypertrophic Cardiomyopathy Association (HCMA) and a Health Equity Board Council Member for equity, diversity and inclusion in rare diseases at the Global Genes. He is a global content editor for regulatory science and an Editorial Board Member of the DIA Global Forum Magazine. He is also an active member of sixteen professional associations, including the Infectious Disease Society of America, American Federation for Medical Research, American Association of Immunologists, American Society for Virology, American Society of Microbiology, Society of Quality Assurance, Association of Clinical Research Professionals, New York Academy of Sciences, International AIDS Society, International Association for Dental Research, American Association for Dental Research, and Regulatory Affairs Professional Society.

LinkedIn: https://www.linkedin.com/in/isaacrc/

Dr. Foster is a seasoned leader in the clinical research industry with a career spanning site ownership, global recruitment innovation, and executive leadership. She started her career in clinical trials on the clinical research side of the industry where she co-owned Metroplex Clinical Research Center in Dallas, TX.  At that time, MCRC was one of the largest private research sites in the country and focused on Rheumatology and Immunology.  In the 1990s, she founded one of the first site management organizations, Rheumatology Research International, a network of 50 clinical sites. She later launched D. Anderson & Company, a global patient recruitment firm that supported major pharmaceutical clients across 100+ countries.  After its acquisition, Dr. Foster co-founded Total Clinical Trials Management, a Dallas-based CRO, which she eventually rebranded as Total Diversity Clinical Trial Management, where she served as Founder and CEO for over a decade, championing inclusive research practices. She has recently transitioned into strategic consulting, advising organizations on site development, patient engagement, and diversity strategy in clinical trials

Mr. Toro is an accomplished consultant and entrepreneur with 28 years of experience. As president and CEO of his own Software Engineering firm, Toro Technologies, Inc., he developed a successful business which delivered critical path systems for MasterCard, AT&T Universal Card, Global Payment Systems and others in the payment industry. Mr. Toro successfully sold his company to PaylinX Corporation (later acquired by publicly traded Cybersource). After his exit, Mr. Toro has worked for over 10 years in structuring capital for growth for his own ventures and others across the Americas. Mr. Toro has an extensive background in Information Technology with emphasis in electronic transaction processing and healthcare information systems.

LinkedIn: https://www.linkedin.com/in/jorgetoroayala/